Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,599 | 162 | 98.0% |
| Education | $74.25 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $722.38 | 14 | $0 (2024) |
| Lundbeck LLC | $517.59 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $412.54 | 16 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $347.30 | 26 | $0 (2024) |
| ABBVIE INC. | $346.83 | 17 | $0 (2024) |
| ITI, Inc. | $326.00 | 10 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $305.48 | 18 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $143.68 | 2 | $0 (2024) |
| Alkermes, Inc. | $119.30 | 3 | $0 (2022) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $78.73 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,127 | 45 | Janssen Pharmaceuticals, Inc ($277.17) |
| 2023 | $860.02 | 26 | Neurocrine Biosciences, Inc. ($366.65) |
| 2022 | $1,386 | 82 | Teva Pharmaceuticals USA, Inc. ($256.88) |
| 2021 | $300.36 | 11 | Neurocrine Biosciences, Inc. ($143.59) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $8.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $115.20 | General |
| Category: Neuropsychiatry | ||||||
| 11/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $118.42 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $80.73 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: PSYCHIATRY | ||||||
| 08/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $59.52 | General |
| Category: PSYCHIATRY | ||||||
| 08/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: PSYCHIATRY | ||||||
| 07/24/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $14.94 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.83 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $129.41 | General |
| Category: Neuroscience | ||||||
| 06/12/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $20.94 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: PSYCHIATRY | ||||||
| 06/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Neuroscience | ||||||
| 05/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Central Nervous System | ||||||
| 05/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.97 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Neuropsychiatry | ||||||
| 05/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 473 | 713 | $83,791 | $46,958 |
| 2022 | 2 | 55 | 110 | $11,518 | $5,649 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 195 | $26,106 | $13,011 | 49.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 83 | 186 | $21,788 | $12,853 | 59.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 95 | 96 | $18,379 | $10,896 | 59.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 76 | 76 | $14,550 | $8,791 | 60.4% |
| 90785 | Psychiatric services complicated by communication factor | Facility | 2023 | 93 | 93 | $1,725 | $810.96 | 47.0% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2023 | 67 | 67 | $1,243 | $596.12 | 48.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 61 | $7,458 | $3,752 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 49 | $4,060 | $1,896 | 46.7% |
About Michael Billock
Michael Billock is a Psychiatric/Mental Health healthcare provider based in Dublin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2021. The National Provider Identifier (NPI) number assigned to this provider is 1962164046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Billock has received a total of $3,673 in payments from pharmaceutical and medical device companies, with $1,127 received in 2024. These payments were reported across 164 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,599).
As a Medicare-enrolled provider, Billock has provided services to 528 Medicare beneficiaries, totaling 823 services with total Medicare billing of $52,607. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Dublin, OH
- Active Since 10/06/2021
- Last Updated 03/17/2023
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1962164046
Products in Payments
- INGREZZA (Drug) $722.38
- ABILIFY MAINTENA (Drug) $417.93
- CAPLYTA (Drug) $404.73
- INVEGA SUSTENNA (Drug) $391.29
- VRAYLAR (Drug) $346.83
- REXULTI (Drug) $337.53
- AUSTEDO (Drug) $273.24
- NUPLAZID (Drug) $143.68
- ARISTADA (Drug) $110.30
- HETLIOZ (Drug) $75.06
- SECUADO (Drug) $55.48
- Austedo XR (Drug) $54.07
- AZSTARYS (Drug) $48.63
- GRALISE (Drug) $46.35
- PERSERIS (Drug) $40.72
- ABILIFY ASIMTUFII (Drug) $35.67
- BRINTELLIX (Drug) $31.94
- SPRAVATO (Drug) $21.25
- UZEDY (Drug) $19.99
- VYVANSE (Drug) $18.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Dublin
Sara Bailey, Aprn, Pmhnp-Bc, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,169
Liliana Simmons, Arnp, ARNP
Psychiatric/Mental Health — Payments: $4,152
Kadori Marshall
Psychiatric/Mental Health — Payments: $2,881
Christy Tompkins, Aprn, APRN
Psychiatric/Mental Health — Payments: $2,531
Ms. Valerie Armor, Msn, Pmhnp-Bc, MSN, PMHNP-BC
Psychiatric/Mental Health — Payments: $2,347
Alexa Kaufman, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $2,121